• Racial Disparities in Treatment of Pregnant Women with Drug Use, Abuse and Dependence

    Oct 1, 2017, 00:00

  • Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products

    Oct 1, 2017, 00:00

  • Diferencias Geográficas En La Salud Auto-Percibida Comunal De Chile

    Oct 1, 2017, 00:00

  • Non-Proportional Hazards in Network Meta-Analysis- Efficient Strategies for Model Building and Analysis

    Oct 1, 2017, 00:00

  • Identifying the Challenges to Adult Influenza Vaccination in Latin America

    Oct 1, 2017, 00:00

  • A Systematic Literature Review of Uk Epidemiology of Brca1 And BRCA2-Mutated Locally Advanced or Metastatic Ovarian Cancer

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Insulin Degludec Versus Insulin Glargine U100 In Type 1 And Type 2 Diabetes Patients From The Portuguese National Healthcare System Perspective- Evidence From The Switch 12 Trials

    Oct 1, 2017, 00:00

  • One Year Cost Of Ischemic Stroke And Intracranial Hemorrage According To Disability For Atrial Fibrillation Patients In France

    Oct 1, 2017, 00:00

  • Resource Utilisation And Related Health Care Costs Among Patients With Multiple Myeloma With ≥ 2 Prior Lines Of Treatment In Finland- Evaluation Based On Finnish Real World Data From Auria Biobank

    Oct 1, 2017, 00:00

  • 2017 Black Box Amnog Rebates- What Is Driving The Rebates?

    Oct 1, 2017, 00:00

  • Treatment Patterns Of Second-Line (2L) Metastatic Urothelial Cancer (MUC) In Spain

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Patients with Metastatic Colorectal Cancer Using EQ-5D-5L

    Oct 1, 2017, 00:00

  • The Associated Factors of Neuropathic Pain Among Chronic Low Back Pain Patients in South Korea- Findings from the NLBP OR

    Oct 1, 2017, 00:00

  • Utilization and Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Predictive Molecular Biomarker (BMX) Tests

    Oct 1, 2017, 00:00

  • Incorporating Dependence Between Model Parameters In Uncertainty Analyses

    Oct 1, 2017, 00:00

  • Generic Competition and ITS Impact on Reference Pricing System and Medicnes Utilization in the Group of Sartans

    Oct 1, 2017, 00:00

  • Barriers To Access And Pricing Negotiations Criterial Selection For Novel Treatments For Hepatitis C In The Greek Healthcare Context

    Oct 1, 2017, 00:00

  • Innovative Contracting- Use Of Complex Managed Entry Agreements

    Oct 1, 2017, 00:00

  • Impact of Disease Activity Measures on Health Utilities in PPMS

    Oct 1, 2017, 00:00

  • The Use of The Propensity Score In The Cost-Effectiveness Analysis of The Atrial Fibrillation Treatment

    Oct 1, 2017, 00:00

  • Cost and Treatment of Asthma and Copd in the Real Practi A Regional Segmentation

    Oct 1, 2017, 00:00

  • An Economic Model To Support Decisions on The Adoption of A Live Vaccine To Aid in The Control of Salmonid Rickettsial Septicaemia (Srs) In Farmed Atlantic Salmon in Chile

    Oct 1, 2017, 00:00

  • Primary Treatment Patterns Among Glaucoma Patients In Korea From 2002 To 2013 Using The National Health Insurance System Claims Data

    Oct 1, 2017, 00:00

  • The Economic Impact Of Providing Dengue Vaccination In The Workplace In Brazil

    Oct 1, 2017, 00:00

  • Programa Stewardship- Otimizando A Terapia Antimicrobiana Com Eficiência Em Um Hospital De Ensino De Referência Em Fortaleza, Ceará

    Oct 1, 2017, 00:00

  • Review Of The Reimbursement Environment For Advanced Therapeutic Medicinal Products (AtmpS) In The Uk

    Oct 1, 2017, 00:00

  • Value of Needleless Safety Devices For IV Voriconazole In Prevention of Needlestick Injury (NSI)

    Oct 1, 2017, 00:00

  • Integrated Care System For Hypertension In China- What The Cost Will Be For Government? A budget impact analysis

    Oct 1, 2017, 00:00

  • Primary Nonadheren Do Differences Exist Between Life Sustaining And Quality Of Life Medications?

    Oct 1, 2017, 00:00

  • Market Access of Advanced Therapy Medicinal Product (ATMP) In Europe- Lessons Learnt And Key Considerations for Future Success

    Oct 1, 2017, 00:00

  • Primary Data Collection Versus use of Retrospective Claims Data- Methodology Lessons Learned from A Linked Database Study in Chronic Obstructive Pulmonary Disease (COPD)

    Oct 1, 2017, 00:00

  • Estimation of The Cost of Metastatic Melanoma in France Using Melbase Data

    Oct 1, 2017, 00:00

  • Evaluating The Addition To Formulary of Belimumab For The Treatment of Systemic Lupus Erythematosus- A Cost-Effectiveness Model

    Oct 1, 2017, 00:00

  • Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) In Patients With Type 2 Diabetes Mellitus In Slovenia

    Oct 1, 2017, 00:00

  • The Cost and Outcomes of Breast Cancer Screening for Women 40-49 Years Old in Russia

    Oct 1, 2017, 00:00

  • Obstructive Sleep Apnea Treatment Guidelines - Implementation Status In Oecd-Countries

    Oct 1, 2017, 00:00

  • Consistency Assessment of International Drug Price Comparisons

    Oct 1, 2017, 00:00

  • The Validity of Objective Response Rate As A Surrogate For Progression-Free And Overall Survival In The Evaluation of First-Line Chemotherapy For Advanced Non-Small Cell Lung Cancer

    Oct 1, 2017, 00:00

  • Pre-Hospital Pain Relief Treatment In Patients With Musculoskeletal Injuries Experiencing Moderate To Severe Pain In Medical Emergencies

    Oct 1, 2017, 00:00

  • Healthcare Costs Associated with Cervical Cancer, Precancerous Lesions, and Genital Warts Treatment in Taiwan

    Oct 1, 2017, 00:00

  • Estimating Survival After Radical Prostatectomy In Prostate Cancer; A Propensity-Score Matching Method

    Oct 1, 2017, 00:00

  • Is Willingness to Pay Higher for Cancer Prevention and Treatment?

    Oct 1, 2017, 00:00

  • Lipid-Lowering Treatment Patterns and Possible Associated Statin Intolerance in Patients with Clinical Atherosclerotic Cardiovascular Disease (ASCVD) or Diabetes Mellitus (DM) in Taiwan

    Oct 1, 2017, 00:00

  • Comparative Effectiveness Of Novel Treatments For Advanced Melanoma- A Systematic Literature Review And Network Meta-Analysis Of Effectiveness And Safety Outcomes

    Oct 1, 2017, 00:00

  • Social Burden of Copd

    Oct 1, 2017, 00:00

  • Alemtuzumab Is The Most Cost-Effective Option In Comparison To Available Therapies In The Treatment of Rrms From The UK NHS Perspective

    Oct 1, 2017, 00:00

  • Comparative Analysis of Lists of Antifungal Preparations for Onychomycosis Treatment In British and Ukrainian National Formularies

    Oct 1, 2017, 00:00

  • A Population-Based Study on Clinical Outcomes and Medical Costs of Laparoscopic Versus Open Surgery for Colon Cancer Patients in Taiwan

    Oct 1, 2017, 00:00

  • Length of Trial Period and Fit of Standard Survival Extrapolation Distributions for Ipilimumab in Melanoma

    Oct 1, 2017, 00:00

  • Market Dynamics of Statin Medications

    Oct 1, 2017, 00:00

  • The Value Of Beds With Continuous Lateral Rotation Therapy To Prevent Ventilator-Associated Pneumonia And Pressure Injuries- A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Comparisons Of Healthcare Utilization And Cost Impact Of Managing Type 2 Diabetes Across The System Of Care In Medicare Beneficiaries

    Oct 1, 2017, 00:00

  • Evaluating Health Impact Of Common Chronic Conditions On Quality Of Life Of EQ-5D-3L In Older Chinese

    Oct 1, 2017, 00:00

  • The Burden of Spondyloarthritis – Paasport A Population-Based Study

    Oct 1, 2017, 00:00

  • Electronic Patient-Reported Outcomes- Are There Gaps Between Guidance And Issues Encountered In Practice?

    Oct 1, 2017, 00:00

  • Systematic Literature Review And Indirect Comparison of Glasdegib Plus Low Dose ARA-C Versus A Hypomethylating Agent For Acute Myeloid Leukemia Patients Ineligible For Intensive Chemotherapy

    Oct 1, 2017, 00:00

  • The Examination Of Location And Frequency Of Pain In Weight Training

    Oct 1, 2017, 00:00

  • Review of Surrogate Endpoint Validation Methodologies and Application In Solid Tumour Htas

    Oct 1, 2017, 00:00

  • Prevalence of Overweight and Obesity Among Health Personnel in an Urban Ghana- A Descriptive Cross-Sectional Study, 2017

    Oct 1, 2017, 00:00

  • Persistence and Adherence to Oral Antiresorptive Therapy in a Fracture Liaison Servi 24-Month Results of a Prospective Cohort Study

    Oct 1, 2017, 00:00

  • The Need For Developing A Decision Aid Tool About Feeding Options

    Oct 1, 2017, 00:00

  • Substantiation of the National Policy of Pricing and Availability of Drugs

    Oct 1, 2017, 00:00

  • The Comparison Among Different Countries’ EQ-5D-5L Value Sets Applied In Chinese General Population

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Continuous Versus Intermittent Celecoxib Use for HIP and Knee Osteoarthritis

    Oct 1, 2017, 00:00

  • A Systematic Review Of Calibration In Population Models

    Oct 1, 2017, 00:00

  • Minimally Important Differen Empirical Comparison Of Estimation Methods Using Orthopaedics And Otolaryngology

    Oct 1, 2017, 00:00

  • Discrete Event Simulation Modelling of Long Term Cost-Effectiveness of Internet-Based Blended Cognitive Behavioural Therapy for Major Depressive Disorder- Extrapolation of the E-Compared Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • Development of a Screening Questionnaire to Detect Heavy Menstrual Bleeding in Women of Child-Bearing Age

    Oct 1, 2017, 00:00

  • Retrospective Analysis of the Use of Incremental Cost-Effectiveness Ratio (Icer) in Technology Incorporation in the Brazilian Public Health System (Sus), 2012-2016, Perspectives and Challenges for the Brazilian Context

    Oct 1, 2017, 00:00

  • Development Of A Tool To Quantify An Individual’s History Of Sun Exposure- Qualitative Phase Of The Development Of The Sun Exposure Questionnaire

    Oct 1, 2017, 00:00

  • Are LABA/LAMA/ICS FDCS A Triple Threat for COPD Competitors in the Cost-Constrained EU5?

    Oct 1, 2017, 00:00

  • Pro Instruments Used in Studies of Skin Cancer Since 1960

    Oct 1, 2017, 00:00

  • Measurement Of Multimorbidity To Predict All-Cause Mortality In A Nationwide Population, Using The French National Health Insurance Database (SNIIRAM)

    Oct 1, 2017, 00:00

  • Value Of Treating All Liver Fibrosis Stages To Reach Elimination Of Diagnosed Chronic Hepatitis C- A Modelling Approach In France

    Oct 1, 2017, 00:00

  • ASSOCIATION Between Second-Line Therapy (2LT) Regimen Type, Duration of Therapy (DOT), and Time To Next Treatment (TTNT) In A United States (US) Relapsed/Refractory Multiple Myeloma (RRMM) Cohort- An Electronic Medical Records (EMR)-Based S ...

    Oct 1, 2017, 00:00

  • Costo De La Diabetes Mellitus En El Sistema De Salud Colombiano

    Oct 1, 2017, 00:00

  • Angiotensin II Receptor Blockers And Intestinal Malabsorption- An Observational Cohort Study In Germany And Italy

    Oct 1, 2017, 00:00

  • New Insights In Metastatic Colorectal Cancer Treatment (MCRC) In 5 European Countries

    Oct 1, 2017, 00:00

  • Approaches To Modelling The Cost-Effectiveness Of Interventions For Heart Failure- A Systematic Review

    Oct 1, 2017, 00:00

  • Willingness To Pay For Qaly In The Czech Republic Between 2013 And 2017- A Review

    Oct 1, 2017, 00:00

  • Healthcare Professionals’ Preferences for the Treatment Selection of Chronic Lymphocytic Leukemia (CLL)- The Prelic Study

    Oct 1, 2017, 00:00

  • Comparison of The Quality of Life In Elderly Population According To The Occurrence of Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of A Novel Breath-Triggered Aerosol Inhaler Which Has Been Designed To Reduce The Critical Handling Error of Insufficient Inspiratory Effort

    Oct 1, 2017, 00:00

  • Economic Evaluation of Romiplostim Vs Eltrombopag In The Treatment of Adult Patients With Chronic Immune Thrombocytopenia In Mexico

    Oct 1, 2017, 00:00

  • Impacto De Una Ley De Bioequivalencia En El Precio De Medicamentos

    Oct 1, 2017, 00:00

  • Vaccines for Herpes Zoster- A Systematic Review of Randomized Controlled Trials In Adults ≥50 Years of Age

    Oct 1, 2017, 00:00

  • Non-Quantifiable Benefit Within The German Amnog System- Factors Contributing To Time Limits Set For Benefit Resolutions And Potential Implications On Price Discounts

    Oct 1, 2017, 00:00

  • A Healthcare Policy Study To Build A Roadmap for Rare Disease Management Under The Egyptian Healthcare System

    Oct 1, 2017, 00:00

  • Long-Term Benefits of LDL Cholesterol Lowering In Young Adulthood- A Computer Simulation Study

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulant (DOAC) Adoption in Practi Utilization, Expenditures, Switching and Adherence

    Oct 1, 2017, 00:00

  • The Cost Of Treating Diabetic Ketoacidosis In The UK- A National Survey Of Hospital Resource Use

    Oct 1, 2017, 00:00

  • External Validation of A Mapping Algorithm To Estimate Eq-5d-3l Utilities From Oxford Knee Score Responses

    Oct 1, 2017, 00:00

  • Patterns of Estimated Glomerular Filtration Rate and Albuminuria in Relation to Progression to Serious Outcomes- Hospitalization for Infection, Major Adverse Cardiovascular Events and Renal Failure

    Oct 1, 2017, 00:00

  • Trends in Pragmatic Clinical Trials

    Oct 1, 2017, 00:00

  • Impact Of Genomic Testing Billing Practices On Utilization In Academic Hybrid Oncology Practice

    Oct 1, 2017, 00:00

  • Overall Survival In Patients With Metastatic Urothelial Cancer By First-Line Therapy

    Oct 1, 2017, 00:00

  • Issues Encountered When Modelling The Long Term Clinical Effectiveness Of Treatments From Short Term Trials Using Second-Line Treatments For Advanced Or Metastatic Renal Cell Carcinoma (AMRCC) As An Example

    Oct 1, 2017, 00:00

  • Increasing Trend On Turkish Un-Licenced Medicine Market- A General Overview Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Easypod™ Device Versus Other Somatotropin Delivery Techniques In Egypt In Treatment of Growth Hormone Deficiency

    Oct 1, 2017, 00:00

  • Risk of Dipeptidyl-Peptidase-4 (Dpp-4) Inhibitors On Site-Specific Cancer- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Comparison Of Costs Between Hospital And Home Infusions In Patients Treated With Laronidase

    Oct 1, 2017, 00:00

  • Competency Analysis Of Community Pharmacists About Correct Use Of Metered Dose Inhaler

    Oct 1, 2017, 00:00

  • A Cost Consequences Analysis of The Human Body Posturizer In Italy

    Oct 1, 2017, 00:00

  • Statistics and Costs of Emergency Care Related to External Causes in One Hospital of Rio De Janeiro City

    Oct 1, 2017, 00:00

  • Real World Data on Multiple Myeloma Treatment Patterns- First and Second-Line Treatment in the Brazilian Public Health System

    Oct 1, 2017, 00:00

  • Real World Evidence In Europe - The Results Of An Expert Survey

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Invasive Fungal Infections Therapies In Febrile Neutropenic Patients With Hematological Malignancies In The Turkish Context

    Oct 1, 2017, 00:00

  • Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis

    Oct 1, 2017, 00:00

  • A Cost Effectiveness Analysis Of Seasonal Quadrivalent Influenza Vaccine In Italy Using A Static Model

    Oct 1, 2017, 00:00

  • Efetividade Na Solicitação De Exames Laboratoriais Na Atenção Básica

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Prasugrel For Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention In Spain

    Oct 1, 2017, 00:00

  • Biosimilars And Reference Biotechnologic Drugs- Comparison Of The Biosimilars’ Effect On Reference Drug’s Price For EU, USA And Turkey

    Oct 1, 2017, 00:00

  • Oral Estrogen Therapy Is Associated With Reduced Risk of Hepatitis B Virus–Related Hepatoma In Taiwanese Postmenopausal Women

    Oct 1, 2017, 00:00

  • Review of Rare Disease Registries Across EU5 Countries

    Oct 1, 2017, 00:00

  • Patient Counts Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013

    Oct 1, 2017, 00:00

  • An Observational Retrospective Cohort Database Study To Estimate Costs Regarding Immunoglobulin Use for Itp Treatment In The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Relevance Of Real World Data In German Amnog Submissions In Oncology

    Oct 1, 2017, 00:00

  • Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients

    Oct 1, 2017, 00:00

  • Calculating The Indirect Costs Of Adult Pneumococcal Disease And The Rate Of Return To The 13-Valent Pneumococcal Conjugate Vaccine (PCV13) In Older Adults, With An Application To Denmark

    Oct 1, 2017, 00:00

  • Tocilizumab after A First-Line with Anti-Tnf in Rheumatoid Arthritis- A Cost-Consequence Analysis in the Italian Setting

    Oct 1, 2017, 00:00

  • Recent Trends in Provider Perceptions and Use of Value Frameworks in the United States (US)

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Obinutuzumab Plus Chlorambucil in Patients with Previously Untreated Chronic Lymphocytic Leukemia and Coexisting Conditions

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Direct Aspiration First Pass Technique (ADAPT) For Thrombectomy Revascularization of Large Vessel Occlusion In Acute Ischemic Stroke (French Health Ministry Prme 16-0020)

    Oct 1, 2017, 00:00

  • Breakfast Consumption And Associated Factors Among Students In Olabisi Onabanjo University, Ogun State, Nigeria

    Oct 1, 2017, 00:00

  • Leveraging Electronic Health Records to Meet The Real World Evidence Needs of Hta- A Uk Perspective

    Oct 1, 2017, 00:00

  • Assessment of Antidiabetic Drugs In Fran What Is The Basis For A Reimbursement Recommendation?

    Oct 1, 2017, 00:00

  • Análise Da Qualidade Da Evidência Científica Entre Xelox E Folfox No Tratamento Do Câncer Colorretal

    Oct 1, 2017, 00:00

  • Indirect Costs and Caregiver Burden of Schizophrenia In European Countries – Results of A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Uses and Applications of Eq-5d in Latin America the Caribbean- Systematic Review and Bibliometric Analysis

    Oct 1, 2017, 00:00

  • Subcutaneous Immunoprophylaxis As A Cost-Effective Treatment Alternative For Hepatitis B Virus-Related Transplant Patients In France

    Oct 1, 2017, 00:00

  • Acceptance of Population-Adjusted Indirect Treatment Comparison Methods In Nice Assessments

    Oct 1, 2017, 00:00

  • Estudio De Costo- Consecuencia De Darbepoetina Alfa Para EL Tratamiento De Anemia Sintomática Derivada De La Enfermedad Renal Crónica En Colombia

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of IVF Treatments Gonal-F® Versus HP-HMG in the United Arab Emirates (UAE)

    Oct 1, 2017, 00:00

  • Minimizing Bias In Indirect Comparisons Utilizing Virtual Patient Level Data

    Oct 1, 2017, 00:00

  • Pharmatool- An Economic and Epidemiological Calculation Tool To Aid Planning For Reducing Cardiovascular Morbidity In Brazil

    Oct 1, 2017, 00:00

  • Incidence, Mortality And Treatment Of Melanoma In Poland In The Years 2012–2016

    Oct 1, 2017, 00:00

  • Comparative Analysis Of Health Technology Assessments Of Drugs For The Treatment Of Multiple Myeloma

    Oct 1, 2017, 00:00

  • Health Technology Assessment Decisions in Immuno-Oncology Therapies- Results, Rationales, and Trends

    Oct 1, 2017, 00:00

  • The Economic Impact of Switching To Herceptin (TRASTUZUMAB) Biosimilar for The Treatment of Metastatic Breast Cancer From A UK Payer Perspective

    Oct 1, 2017, 00:00

  • European Real World Data Sources To Characterise Flares In Patients With Systemic Lupus Erythematosus- A Review

    Oct 1, 2017, 00:00

  • Custo De Tratamento Biológico Em Pacientes Com Doenças Reumáticas Em Uma Operadora De Saúde De Fortaleza/Ce

    Oct 1, 2017, 00:00

  • Potential Therapeutic and Economic Value of Risk-Stratified Treatment as Initial Treatment of Multiple Myeloma in Europe

    Oct 1, 2017, 00:00

  • Health-Related Quality-Of-Life And Utility Measures Impact In A Randomized Controlled Study Of Fine Needle Aspiration Cytology (FNAC) Versus Watchful Observation In Patients With Incidental Symptomatic Thyroid Nodules

    Oct 1, 2017, 00:00

  • Impacto Económico En Las Patologías De Salud Mental, Neurológicas Y Demencias En Colombia

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Arterial Hypertension In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • Costs of Grade 3 and 4 Adverse Events Associated with Current Cancer Treatments - Cost Estimations For Sweden, Norway, Finland And Denmark

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Interferon-Free Treatment Strategies For Hepatitis C After Generic Entry Of Direct-Acting Antivirals In The Kazakhstan

    Oct 1, 2017, 00:00

  • Modelling The Burden Of Cardiovascular Disease In Turkey And The Impact Of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • Treatment in Transplant Eligible Multiple Myeloma Patients in Macedonia- Development of Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Economic Analysis And Evaluation Of The Value Of The Parallel Export Of Medicinal Products For Treatment Of Oncological Diseases In Bulgaria, 2016 T. VEKOV 1 AND G. KOLEV2

    Oct 1, 2017, 00:00

  • The Economic Impact of Rheumatoid Arthritis on Patients’ Households. An Estimation of The Disease Related Catastrophic Health Expenditure, In Greece

    Oct 1, 2017, 00:00

  • Healthcare Resource Use And Economic Burden Attributable To Respiratory Syncytial Virus In The United States

    Oct 1, 2017, 00:00

  • Positive Externalities of austerity? The Case of Smoking Cessation During the Financial Crisis in Greece

    Oct 1, 2017, 00:00

  • Using A Mixed Methods Approach To Determine The Item-Scale Structure and Scoring for Clinical Outcome Assessments

    Oct 1, 2017, 00:00

  • Symptom Deterioration in Patients with Metastatic Renal Cell Carcinoma Treated with Cabozantinib or Everolimus

    Oct 1, 2017, 00:00

  • Price Life Cycle Management Of Orphan Drugs In France

    Oct 1, 2017, 00:00

  • Copyright/Subscription

    Oct 1, 2017, 00:00

  • A Web-Based Hub Spoke Model For The Management Of HCV Patients And Innovative Treatments- The Resist - HCV Sicily Network Experience

    Oct 1, 2017, 00:00

  • Evaluation of Appropriateness of Antibiotics in the Intensive Care Unit of a Tertiary Care Hospital

    Oct 1, 2017, 00:00

  • Cost Analysis of Several Treatment Sequences Used for The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal- The Case for Cladribine Tablets

    Oct 1, 2017, 00:00

  • Multivariate Network Meta-Analysis of Survival Function Parameters

    Oct 1, 2017, 00:00

  • Burden and Cost of Cancer Treatment in the Private Healthcare Setting in São Paulo State

    Oct 1, 2017, 00:00

  • Evaluation of The Long-Term Cost-Effectiveness Of Real Time Continuous Glucose Monitoring (RTCGM) Versus Self Monitoring Of Blood Glucose (SMBG) Alone In Type 1 Diabetes From The Swedish Societal Perspective

    Oct 1, 2017, 00:00

  • Retrospective Analysis of The Burden of Cytomegalovirus Disease In Immunosuppressed Patients After Haematopoietic Cell Transplantation In England

    Oct 1, 2017, 00:00

  • Factors Affecting Polypharmacy in Elderly Patients with Diabetes in Greece

    Oct 1, 2017, 00:00

  • Agreement Between Patient And Clinician Ratings Of Disease Severity In Hidradenitis Suppurativa, Rheumatoid Arthritis, And Chronic Plaque Psoriasis

    Oct 1, 2017, 00:00

  • Direct Costs of Long-Term Psychiatric Hospitalization in Public Hospital of the State of Sao Paulo, Brazil- The Complexo Hospitalar Juquery Case

    Oct 1, 2017, 00:00

  • Estimation Of Health-Related Quality Of Life (HRQOL) In Cancer Patients Utilising A Time-To-Death Analysis

    Oct 1, 2017, 00:00

  • Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Patients with Relapsed or Refractory Multiple Myeloma

    Oct 1, 2017, 00:00

  • Economic Burden of Hospitalizations Related To Pulmonary Arterial Hypertension (PAH) In France

    Oct 1, 2017, 00:00

  • Direct Costs of Health Care of Cystic Fibrosis, The Case of A Health Insurer In Colombia

    Oct 1, 2017, 00:00

  • A Review of The Quality of Life and Educational Burden of Allergic Rhinitis on Adolescents

    Oct 1, 2017, 00:00

  • Comparing Quality of Life of (RT-PA) with No-(RT-PA) in Stroke Attacked Patients

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Rhtnk-TPA Compared With RT-PA In The Treatment of Acute St-Segment Elevation Myocardial Infarction (Stemi) In China

    Oct 1, 2017, 00:00

  • Regional Policies Impact on Biosimilar Adoption For Autoimmune Diseases In Italy

    Oct 1, 2017, 00:00

  • Mixed Methods Evaluation of An Itch Numeric Rating Scale Among Adult and Adolescent Patients With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Special Considerations for Conducting Qualitative Interviews With Cancer Patients and Their Caregivers for The Purpose of Developing Clinical Outcome Assessments

    Oct 1, 2017, 00:00

  • Assessment of Hiv-Antiretroviral Adherence Using Refill Data From a National Administrative Database in Brazil

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Posaconazole Versus Fluconazole in The Prophylaxis of Invasive Fungal Infections in Acute Leukemia Patients in Colombia

    Oct 1, 2017, 00:00

  • Long Term Efficacy of Pertuzumab For HER2+ Metastasic Breast Cancer Ecuadorian Population

    Oct 1, 2017, 00:00

  • The Role of Stakeholder Engagement in E-Health and the use of Big Data to Predict Health Outcomes

    Oct 1, 2017, 00:00

  • Patient Reported Outcome Of Celiac Disease

    Oct 1, 2017, 00:00

  • Exploring The Efficacy And Safety of Radiofrequency Ablation In Patients With Spinal Metastases- A Systematic Review

    Oct 1, 2017, 00:00

  • Characteristics of Latin American Patients With Rheumatoid Arthritis Receiving Advanced Therapy

    Oct 1, 2017, 00:00

  • Integrated 2 Screw De-Rotation/Compression, Cepahlo-Medulary Device Reduces Implant Related Complications and Improves Health Related Quality of Life in Patients with Intertrochanteric Fractures, A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Financial Group Incentives Improving Medication Persistence - Health Behavior Engineering Approach

    Oct 1, 2017, 00:00

  • Mapping Acroqol Scores to EQ-5D to Obtain Utility Values for Patients with Acromegaly

    Oct 1, 2017, 00:00

  • Which Are The Most Common Quality of Life Health States In Latin America? A Pareto Analysis of A Collaborative Project Using Euroqol Eq-5d In Argentina, Brazil, Chile and Uruguay

    Oct 1, 2017, 00:00

  • Systematic Literature Review of the Impact of Asthma Support Programs Dedicated to Adult Patients

    Oct 1, 2017, 00:00

  • Second-Line Treatments For Advanced Gastric Cancer- A Network Meta-Analysis Of Overall Survival Using Parametric Modelling Methods

    Oct 1, 2017, 00:00

  • Horizon Scanning In Oncology – Rapid Scanning Approach In Slovakia

    Oct 1, 2017, 00:00

  • A Markov Microsimulation Model For The Economic Evaluation Of Partially Implantable Active Middle Ear Implants In Sensorineural Hearing Loss

    Oct 1, 2017, 00:00

  • Increased Episode Rate of Medically-Attended Acute Gastroenteritis In Diabetics In England

    Oct 1, 2017, 00:00

  • Lacosamide As First Line Treatment Option In Focal Epilepsy; A Cost-Utility Analysis for The Greek Healthcare System

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Dabigatran with Real World Effectiveness Evidence

    Oct 1, 2017, 00:00

  • Spirometry Comparison Between Smokers and Non-Smokers Students in University of Balochistan,Quetta, Pakistan

    Oct 1, 2017, 00:00

  • Factors Contributing to the Ceiling Effect Among Patients with Prostate Cancer who Were Judged to Have “Full-Health” by EQ-5D-5L

    Oct 1, 2017, 00:00

  • Identification of Assessment and Funding Models Applicable to Companion Diagnostics in UK, France And Germany

    Oct 1, 2017, 00:00

  • Comparison Of Costs And Care Of Lung Cancer Patient At The End-Of-Life In Germany Depending On The Time Of Survival After Diagnosis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation Of Phid-CV Versus PCV-13 In Slovakia

    Oct 1, 2017, 00:00

  • Analysis Of The Behavior Of The Expenditure Curve In Oncology And Other Causes Of Death In The Last 5 Years Of Life – Brazil Real-World Health Care Data

    Oct 1, 2017, 00:00

  • Quality of Life and Economic Burden Among Chronic Obstructive Pulmonary Disease (Copd) Patients in Japan

    Oct 1, 2017, 00:00

  • Cost Impact Analysis of Needlestick Injuries In India

    Oct 1, 2017, 00:00

  • Coverage Evidence Development in the Course of the Drug Reevaluation in Korea

    Oct 1, 2017, 00:00

  • The Personalised Reimbursement Models (Prm)- Real World Data Collection to Provide Innovative Pricing Solutions in France

    Oct 1, 2017, 00:00

  • Cost Analysis Of Drug-Related Probelms In Saudi Arabia, Patient And Health Care Professional's Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Comparison of Opoid Substitution Therapy Vs. Non-Pharmcologic Therapy In The State of Kuwait

    Oct 1, 2017, 00:00

  • Association Between Socioeconomic Deprivation And Cancer Incidence And Outcomes Among English CCGS

    Oct 1, 2017, 00:00

  • Multiple Myeloma Patients’ Profile and Regimens Transitions in the Brazilian Private Health Sector

    Oct 1, 2017, 00:00

  • Selective Internal Radiotherapy (SIRT) in Metastatic Colorectal Cancer Patients with Liver Metastases- Preliminary Primary Care Resource Use and Utility Results from The Foxfire Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • Economic Benefits of SFLT-1/PLGF Testing for Preeclampsia in Colombia- A Fiver Year Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Health-Economics Evaluations in France, England, Canada and Autralia- Comparison of Methodologies and Impact on Drugs’ Access To Patients

    Oct 1, 2017, 00:00

  • Indicators of Participation in Cervical Cancer Screening Among Romany Women

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Colombia

    Oct 1, 2017, 00:00

  • Prevalence of Cardiovascular Disease In Type 2 Diabetes- A Global Systematic Review

    Oct 1, 2017, 00:00

  • Do Characteristics of Patients Influencing the Choice of Pain Treatment by GPS Differ in Osteoarthritis and Cancer? – An Italian Real World Evidence Study

    Oct 1, 2017, 00:00

  • Evaluation Of Wearable Technology Use In Clinician Outcomes Assessment Studies

    Oct 1, 2017, 00:00

  • Exploring Structural Uncertainty With An Open-Source Cost-Effectiveness Model For Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Pentaray High Density Mapping Catheter In Treatment Of Ventricular Tachycardia In Turkey

    Oct 1, 2017, 00:00

  • Comparison of The Long-Term Cost-Effectiveness of Ideglira Versus Multiple Daily Insulin Injections In The Spanish Setting Using Real-World Clinical Data

    Oct 1, 2017, 00:00

  • Probabilistic Sensitivity Analysis And Its Role In Assessment Of Profitability In Poland

    Oct 1, 2017, 00:00

  • Cost Utility Analysis of Infliixmab and Adalimumab Compared with Conventional Therapy in Patients with Crohn Disease in the Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Psoriasis (PSO) Patients’ Profile And Impact of The Disease on Patients’ Quality of Life and Work Productivity In A Real-Life Setting In Brazil

    Oct 1, 2017, 00:00

  • Utilization of Lipid-Lowering Drugs in Slovakia- Comparison of Data from Different Sources

    Oct 1, 2017, 00:00

  • The Economic Impact of Dietary Sodium Reduction In Canada

    Oct 1, 2017, 00:00

  • Patients Acknowledge Adaptation- The Case Of Amputees

    Oct 1, 2017, 00:00

  • Burden of Illness Associated With Anaemia In Chronic Kidney Disease In Japan- A Literature Review

    Oct 1, 2017, 00:00

  • Demand And Supply Side Regulation Of Biosimilar Markets In Germany, France And England And Its Implications For Market Access Of Biosimilars

    Oct 1, 2017, 00:00

  • Comparing The Estimated Health And Economic Benefits Of Herpes Zoster (HZ) Vaccines In The UK

    Oct 1, 2017, 00:00

  • A Conceptual Yet Pragmatic Framework for Value-Based Agreements

    Oct 1, 2017, 00:00

  • Reporting Quality Transparency Of Published Network Meta-analysis. Is it Satisfactory?

    Oct 1, 2017, 00:00

  • Sulfadiazine-Pyrimethamine Versus Sulfamethoxazole-Trimethoprim For Treatment of Toxoplasmic Encephalitis in Hiv/Aids Patients- A Cost Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Providing A Framework For Assessing Access To Medicine

    Oct 1, 2017, 00:00

  • Resultados De La Implementación De Una Estrategia Combinada De Educación Y Gestión De Pacientes En Centros De Atención Primaria De Argentina

    Oct 1, 2017, 00:00

  • Hepatitis C Virus- Determinants Of Patients’ Management Costs

    Oct 1, 2017, 00:00

  • Cost-Utility Of Novel Tests After A Negative Prostate Biopsy

    Oct 1, 2017, 00:00

  • Evaluating the Long-Term Impact of Improving Care for Patients with Type 2 Diabetes in China

    Oct 1, 2017, 00:00

  • A Comparison Of Markov Cohort And Discrete Event Simulation Models In Cost-Effectiveness Analysis Of Sorafenib And Everolimus In 3rd Line Metastatic Renal-Cell Carcinoma In The Czech Republic

    Oct 1, 2017, 00:00

  • Representing Uncertainty In Economic Evaluations- Getting More From PSA Results

    Oct 1, 2017, 00:00

  • Initiative To Obtain Advanced Therapeutic Outcomes In Multiple Myeloma (Importa Project)

    Oct 1, 2017, 00:00

  • What Are The Images Used To Diagnose And Assess Suspected Strokes?- A Systematic Literature Review Of Care In Four European Countries

    Oct 1, 2017, 00:00

  • Understanding Stakeholder Expectations for Patient Engagement- A Qualitative Survey

    Oct 1, 2017, 00:00

  • Bayesian Methodology Considering Historical Data To Predict Overall Survival From Immature Trial Data In Oncology

    Oct 1, 2017, 00:00

  • Using Network Meta-Analysis Of Individual Patient Data (IPD) Summary Aggregate Data (SAD) To Identify Which Combinations Of Interventions Work Best For Which Individuals

    Oct 1, 2017, 00:00

  • Application Study of the EQ-5D-5L in Oncology- Linking Self-Reported Quality of Life of Patients with Metastatic Colorectal Cancer to Clinical Data from a German Tumor Registry

    Oct 1, 2017, 00:00

  • German Amnog Benefit Assessment- The Type Of Appropriate Comparator Makes The Difference

    Oct 1, 2017, 00:00

  • Model Attention Improve The Hospital Nutrition Processes Under The Center Of Excellence Concept

    Oct 1, 2017, 00:00

  • A Quality-Adjusted Time without Symptoms of Disease And Toxicity (Q-TWIST) Analysis Comparing Nivolumab and Therapy Of Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of ...

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Oncology – Are we Getting Better?

    Oct 1, 2017, 00:00

  • The Economic Burden of Breast Cancer in Russia

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact In The Emergency Frequency At Patients With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • Impact of Golimumab, An Anti-Tnfα Monoclonal Antibody, On Health Related Quality of Life (Hrqol) And Work Productivity In Patients With Active Psoriatic Arthritis- 24-Week Results of The Phase Iii Go Vibrant Trial

    Oct 1, 2017, 00:00

  • Chronic Heart Failure (CHF) In The Czech Republic- Cost-of-Illness Analysis Disease Burden Based on Ahead Registry Data Mining

    Oct 1, 2017, 00:00

  • Quantifying The Relationship Between Hyperkalaemia And Outcomes In Patients With Heart Failure Or Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Pharmacoeconomics Analysis of Sertindole Use In The Treatment of Schizophrenia In Russia

    Oct 1, 2017, 00:00

  • A Predictive Tool For Characterizing And Visualizing Populations Under Counterfactual Treatment Assignment

    Oct 1, 2017, 00:00

  • Transfusion Trends In Primary and Revision Total Joint Arthroplasty- Are Recent Declines Shared Equally?

    Oct 1, 2017, 00:00

  • Differences In Vaccine Pricing Between High-Income And Low-Income Markets

    Oct 1, 2017, 00:00

  • Quality of Life for Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (PNF)

    Oct 1, 2017, 00:00

  • Financial Consequences of The Performance of A Pd-L1 Test To Select Patients Receiving Second and Third Line Treatments for Non-Small Cell Lung Cancer in Italy

    Oct 1, 2017, 00:00

  • Antibiotic Stewardship Policy in Biella General Hospital (Italy)- A Five-Year Surveillance

    Oct 1, 2017, 00:00

  • Surveillance Status, Diagnostic Accuracy And Survival Of The National Liver Cancer Surveillance Program

    Oct 1, 2017, 00:00

  • Burden of Disease for Rheumatoid Arthritis In Argentina, Brazil, Colombia, Mexico and Venezuela

    Oct 1, 2017, 00:00

  • Economic Evaluation For Establishing Stroke Unit Followed By Early Supported Discharge In Egypt

    Oct 1, 2017, 00:00

  • Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

    Oct 1, 2017, 00:00

  • Varying Nature Of The Assessment Of Advanced Medicinal Products (Atmp) In Germany

    Oct 1, 2017, 00:00

  • Treatment Patterns Among Newly Diagnosed Diabetes Patients in Dubai

    Oct 1, 2017, 00:00

  • Health Economics And Outcomes Research Needs Assessment For Latin America- Relationship Between Perceived And Expected Quality Of Knowledge In A Self-Assessment Survey

    Oct 1, 2017, 00:00

  • Exenatide In Obese Or Overweight Patients Without Diabetes- A Systematic Review And Meta-Analyses Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

    Oct 1, 2017, 00:00

  • Analysis of Oral Hypoglycemic Drugs Consumption in Ukraine in 2015

    Oct 1, 2017, 00:00

  • Loss Of Response Of Anti TNF-Α Agents As The Second-Line Therapy In Inflammatory Bowel Disease- Based On Korean National Insurnance Claims Data

    Oct 1, 2017, 00:00

  • Cross-Cultural Adaptation And Validation Of The PEDSQL Cardiac Module Version 3.0

    Oct 1, 2017, 00:00

  • The Impact Of The Study Design Submitted For The Early Benefit Assessment On The Pricing For Oncologic Drugs

    Oct 1, 2017, 00:00

  • Federal Spending on Infliximab in Brazil- An Analysis of Purchases from 2007-2015

    Oct 1, 2017, 00:00

  • Economic Impact of Alirocumab In The Management of Primary Hypercholesterolemia or Mixed Dyslipidemia- An Italian Perspective

    Oct 1, 2017, 00:00

  • Evaluating Physicians’ Perception Of Limitations And Obstacles Against The Effectiveness Of “Audit And Feedback” And “Printed Educational Materials” Interventions On Prescribing Behavior- A Qualitative Study

    Oct 1, 2017, 00:00

  • South West Icers – The Experience of Nice’s Diagnostics Assessment Programme

    Oct 1, 2017, 00:00

  • Rotavirus Vaccination May Reduce Acute Gastroenteritis Rates Across All Age Groups In England

    Oct 1, 2017, 00:00

  • Challenges in Optimising Real World Evidence for Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Economic Burden of Cardiovascular Disease In Type 2 Diabetes- A Systematic Review

    Oct 1, 2017, 00:00

  • Non Adherence to Inhalational Medications and Associated Factors Among Patients with Asthma in A Referral Hospital in Ethiopia, Using Validated Tool Tai

    Oct 1, 2017, 00:00

  • Functional Assessment After Treatment Of Upper Extremity Soft Tissue Sarcomas Using Structured Outcome Measures- A Systematic Review

    Oct 1, 2017, 00:00

  • The Economic Burden of Chronic Obstructive Pulmonary Disease In The Spanish Region of Extremadura

    Oct 1, 2017, 00:00

  • Análise De Custo Minimização Na Substituição De Infliximabe Por Seu Biossimilar No Sistema De Saúde Suplementar Brasileiro

    Oct 1, 2017, 00:00

  • Lower Hemoglobin (HB) Levels Negatively Impact Quality Of Life (QOL) Among Peritoneal Dialysis (PD) Patients- Results From A National Representative Cohort Study In Brazil (BRAZPD)

    Oct 1, 2017, 00:00

  • Reporting Clinical Outcomes In Tavi Registries

    Oct 1, 2017, 00:00

  • Antihypertensive Drug Prescription Patterns and their Impact on Outcome of Blood Pressure in Ethiopia-A Hospital-Based Observational Study

    Oct 1, 2017, 00:00

  • What's the Reality of Real-World Evidence in Health Technology Appraisal?

    Oct 1, 2017, 00:00

  • Reliability Testing Of The Finnish Version Of The Non-Technical Skills Scale For Trauma (T-Notechs)

    Oct 1, 2017, 00:00

  • Influência Dos Fatores Socioeconômicos Na Incidência De Câncer De Mama- Revisão Sistemática

    Oct 1, 2017, 00:00

  • Value Of A Pilot Study In A Retrospective Chart Review- Final Protocol Design Should Base On Pilot Results

    Oct 1, 2017, 00:00

  • Cost-Utility Of Liquid Chromatography -Tandem Mass Spectrometry (LC-MS/MS)-Based Urine Analyses To Improve Adherence To Antihypertensive Treatment

    Oct 1, 2017, 00:00

  • Impact of Collaborative Coustomized Patient Education in Psychiatric Diseases

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Using Solifenacin And Modified-Release Tamsulosin Fixed Dose Combination for Treatment of Storage Symptoms Associated With Benign Prostatic Hyperplasia

    Oct 1, 2017, 00:00

  • New European Medical Device Directive (MDD) Comes Into Effect In 2020- Chances And Consequences For Stakeholders

    Oct 1, 2017, 00:00

  • Prescription Analysis on Off-Label Drugs In Pediatric Patients Using The Claims Data of The National Health Insurance In Korea

    Oct 1, 2017, 00:00

  • Aplicação Da Mcda Nas Tomadas De Decisão Sobre Investimento Em Saúde – Uma Revisão Sistemática

    Oct 1, 2017, 00:00

  • Comorbidities in Multiple Sclerosis- A Descriptive Longitudinal Clustering Analysis of Healthcare Resource Utilization Among MS Patients in IBM Explorys Database

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of A Physician-Implemented, Medication Screening Tool in Older Hospitalised Patients in Ireland

    Oct 1, 2017, 00:00

  • Economic Evaluations of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain- A Systematic Review

    Oct 1, 2017, 00:00

  • Patient-Preferred Design Features Of Tnf Inhibitor Self-Injection Devices- Insights From A Rheumatoid Arthritis Auto-Injector Preference Study

    Oct 1, 2017, 00:00

  • European Study on Acute Cough in Children- Results of Poland

    Oct 1, 2017, 00:00

  • Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Mexico

    Oct 1, 2017, 00:00

  • Treatment Switching and Power of ITT and RPSFTM

    Oct 1, 2017, 00:00

  • Expenditure On Non-Pharmaceutical Products In Ireland During A Period Of Healthcare Cost Containment

    Oct 1, 2017, 00:00

  • National Adoption of New Immunossupresants for Solid Organs and Stem Cells Transplantations

    Oct 1, 2017, 00:00

  • Cost Implications Of Tedizolid Introduction For The Treatment Of Complicated Skin And Soft Tissue Infections In A Russian Multi-Field Hospital

    Oct 1, 2017, 00:00

  • Facilitators and Barriers to Adult Vaccination in South East Asia and Latin America

    Oct 1, 2017, 00:00

  • Situation of Rheumatoid Arthritis Patients Treated with Biologics In Germany Based on a Claims Data Analysis

    Oct 1, 2017, 00:00

  • A Real World Evidence Model To Compare Direct Oral Anticoagulants Safety Outcomes For Atrial Fibrillation Patients In Spain

    Oct 1, 2017, 00:00

  • Utilization Patterns of Lipid-Lowering Therapies in Patients at High Risk for or with Atherosclerotic Cardiovascular Disease- A Population-Based Study in South Korea

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Standard Therapy with Phosphocreatine VS Standard Therapy In Perioperative Management of Cardiac Surgery Patients With Extracorporeal Circulation, With Ischemic Heart Disease or With Chronic Heart Insufficienc ...

    Oct 1, 2017, 00:00

  • Health Valuation of Dialysis with the EQ-5D- Determinants of Discrepancy Between Patients and Society

    Oct 1, 2017, 00:00

  • Comparison Of Previous IPHA-HSE Agreement Effects On The Hta Assessment Process In Ireland (2009 – 2016)

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Ziprasidone Use In The Treatment of Schizophrenia In Russia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Afatinib, Gefitinib, Erlotinib, and Pemetrexed-Based Chemotherapy as First-Line Treatments for Egfr Mutation Positive, Advanced Non-Small Cell Lung Cancer in China

    Oct 1, 2017, 00:00

  • Developing A Methodology For Using Acoustic Simulations Of Hearing Loss To Describe Health States

    Oct 1, 2017, 00:00

  • Survival Rates In Primary Hepatic Carcinoma Patients With Cirrhosis In South Korea- A Retrospective Analysis of 68,328 Patients In The National Cancer Registry

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Radiofrequency Catheter Ablation Of Atrial Fibrillation Based On Real-World Data- Manual Or Robotic?”

    Oct 1, 2017, 00:00

  • Quantity And Quality Of External Event Validation Procedures Performed In Published Health Economic Models In Obesity- Outcomes Of A Systematic Review

    Oct 1, 2017, 00:00

  • Economic Burden Of Hospitalized Diarrheal Disease In Bangladesh

    Oct 1, 2017, 00:00

  • Allowing Methadone’s Prescription To General Practitioners- A Positive Impact on The French Healthcare Insurance Expenditures

    Oct 1, 2017, 00:00

  • The Practical Application of a Digital Therapeutic Education Platform for Cardiovascular Rehabilitation

    Oct 1, 2017, 00:00

  • Variation In Opioid Utilization By Physician Specialty And Payer Using A Linked Claims-Emr Database

    Oct 1, 2017, 00:00

  • The Burden Of Albinism- Creation Of A Questionnaire

    Oct 1, 2017, 00:00

  • A Sistematic Review Of The Cost-Effectiveness Of Vaccinating Elderly With The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23)

    Oct 1, 2017, 00:00

  • Cost-Utility of Idelalisib In Combination with Rituximab In Relapsed or Refractory Chronic Lymphocytic Leukemia

    Oct 1, 2017, 00:00

  • The Impact Of Co-Morbidity On The Disease Burden Of VTE

    Oct 1, 2017, 00:00

  • Coverage-With-Evidence-Development (CED) In Germany- Status QUO

    Oct 1, 2017, 00:00

  • Establishing A Medication Error Reporting And Monitoring Programme In A Developing Country’s Tertiary Care Teaching Hospital

    Oct 1, 2017, 00:00

  • Use of Thalidomide In Erythematosus Lupus Treatment

    Oct 1, 2017, 00:00

  • Value Health With A Mobile APP- The Infant Health-Related Quality Of Life Instrument

    Oct 1, 2017, 00:00

  • How Much Sexual Violence Against Women Costs To Brazil?

    Oct 1, 2017, 00:00

  • Estimation of The Health Benefit Associated With A Potential Denosumab-Induced Extension of Progression Free Survival In Multiple Myeloma Patients

    Oct 1, 2017, 00:00

  • Development Of A Mortality Risk Prediction Tool For Patients With Heart Failure Or Chronic Kidney Disease At Risk Of Hyperkalaemia

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Systematic Evaluation of Bevacizumab Treatment for Advanced Non-Small Cell Lung Cancer in China

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Healthcare Resource Utilization And Productivity Loss

    Oct 1, 2017, 00:00

  • Antecipação Ao Rol De Procedimentos Da Agência Nacional De Saúde Suplementar- Impacto Orçamentário Da Incorporação De Um Novo Inibidor De Tirosina-Quinase

    Oct 1, 2017, 00:00

  • Factores Asociados A La Automedicación En Usuarios De Boticas Y Farmacias En Perú- Análisis De La Encuesta De Satisfacción De Los Servicios De Salud (ENSUSALUD) 2015

    Oct 1, 2017, 00:00

  • Will It Blend? Incorporation Of IRP Within HTA Systems

    Oct 1, 2017, 00:00

  • Secukinumab Vs. Adalimumab for the Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis at 48 Weeks from an Argentinian Perspective

    Oct 1, 2017, 00:00

  • Cost Saving Analysis of Encephalogram Bispectral Index Monitoring (Bis) During Ten Different Types of Elective Surgeries in Colombia

    Oct 1, 2017, 00:00

  • Resource Utilisation And Costs Associated With Intravenous Patient-Controlled Analgesia Morphine For Post-Operative Pain Management In A Teaching Hospital Setting In Ireland

    Oct 1, 2017, 00:00

  • How To Aggregate Various Values of Medical Devices Innovation?; A Review of Empirical Work

    Oct 1, 2017, 00:00

  • Are Pharmaceutical Companies Prioritizing Multi-Indication Drugs?

    Oct 1, 2017, 00:00

  • Low Density Lipoprotein Cholesterol (LDL-C) Target Goal Achievement Rate According to Physicians’ Compliance to Established Clinical Guidelines from National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) and American Colleg ...

    Oct 1, 2017, 00:00

  • Incidence of Psychiatric Disorders in Women WITH a Suspected But Unconfirmed Diagnosis of Breast or Genital Organ Cancer

    Oct 1, 2017, 00:00

  • Analysis of Factors Influencing the Level of Actual Benefit in Health Technology Assessment

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life of Patients with Osteoporosis Treated with Teriparatide

    Oct 1, 2017, 00:00

  • Quality of Life of Pregnant Women in Russian Federation

    Oct 1, 2017, 00:00

  • Analyzing the Treatment Cost of Liver Cirrhosis from Healthcare Payer’s Perspective of Vietnam in 2015

    Oct 1, 2017, 00:00

  • Antibiotic Prescribing Pattern In Acute Upper Respiratory Tract Infections In Dubai

    Oct 1, 2017, 00:00

  • ALK Immunohistochemical Test In The Detection Of Patients Affected By ALK+ Non-Small Cell Lung Cancer- Clinical And Budget Impact

    Oct 1, 2017, 00:00

  • Inconclusive Eviden Can Pharmacoeconomics Tilt The Balance?

    Oct 1, 2017, 00:00

  • The Epidemiology and Burden of Paediatric Multiple Sclerosis- Systematic Literature Review

    Oct 1, 2017, 00:00

  • Digital Real-World Evidence Platform- Taking the Burden Out of Melanoma Pain Reporting

    Oct 1, 2017, 00:00

  • Assessment of Medicines For Very Rare Conditions- Review of A New Approach within The Scottish Medicines Consortium

    Oct 1, 2017, 00:00

  • Newly Diagnosed Multiple Myeloma (NDMM) Patient Profiles; Findings From An Observational Chart Review In France, Germany, Italy, Spain And The United Kingdom

    Oct 1, 2017, 00:00

  • A Societal Utility Study to Elicit Values for Adverse Events and Surgical Complications in Moderate to Severe Crohn’s Disease in UK

    Oct 1, 2017, 00:00

  • How does high meld score increases total expenditure on health system? A micro-costing prospective cohort study

    Oct 1, 2017, 00:00

  • A Systematic Review Of Economic Evaluations In Robot-Assisted Hysterectomy Use For Cervical Cancer Compared With Open And Laparoscopic Surgery

    Oct 1, 2017, 00:00

  • An Empirical Analysis of The Role of Learning by Doing in Dynamic Cost-Effectiveness

    Oct 1, 2017, 00:00

  • Comparison Of Post-Creation Procedures And Related Costs Between Traditional Surgical Versus A New Endovascular Approach To Creating An Arteriovenous Fistula- A Usrds Comparison

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Alectinib Compared To Chemotherapy for The Treatment of Treatment-Naïve Patients With Alk Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Greece

    Oct 1, 2017, 00:00

  • Psoriasis Drugs in Europe - Market Access Decisions in Comparision Based on the Prismaccess Database

    Oct 1, 2017, 00:00

  • When The Outcome of An Appraisal Is Not Ni A Review Of Nice Appeals

    Oct 1, 2017, 00:00

  • Treatment Satisfaction Among Patients with Moderate-to-Severe Plaque Psoriasis in Brazil

    Oct 1, 2017, 00:00

  • Evidence Map of Costs Studies In Cystic Fibrosis Since 2000

    Oct 1, 2017, 00:00

  • Systematic Review Of Statins Effectiveness In Prevention Secondary In Elderly

    Oct 1, 2017, 00:00

  • A Review Of Economic Evaluations Considering Screening Interventions For The Risk Assessment Of Venous Thromboembolism In Women Considering Combined Oral Contraceptives

    Oct 1, 2017, 00:00

  • The Effect Of Chronic Diseases, Financial Hardship And Personality Types In Patient's Medication Adherence

    Oct 1, 2017, 00:00

  • Burden Disease of Aortic Stenosis Associated in Patients Undergoing Transcatheter Aortic Valve Replacement

    Oct 1, 2017, 00:00

  • Are We Prep-Ared For Differences Between Nice And SMC Decision Making?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of The Sufentanil Sublingual Tablet System Vs Iv Pca Morphine For The Treatment of Acute Moderate To Severe Post-Operative Pain In Ireland

    Oct 1, 2017, 00:00

  • Caracterización Del Riesgo Cardiovascular Por Factores Asociados- Análisis De Base De Datos De UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Mejoramiento De Los Resultados Clínicos En Pacientes Con Reemplazos De Cadera Y Rodilla

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Supraciliary Micro-Stent Glaucoma Implant Combined With Cataract Surgery In Management Of Primary Open-Angle Glaucoma (POAG) From The Canadian Payer Perspective

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Ixabepilone Monotherapy in Patients with Advanced or Metastatic Breast Cancer Resistant To Anthracyclines, Taxanes and Capecitabine

    Oct 1, 2017, 00:00

  • Judicialização Da Saúde No Brasil- Proximidade Dos Magistrados Com As Políticas Públicas De Saúde

    Oct 1, 2017, 00:00

  • Analysis of Real Data for Treatment of Preterm Birth in Pregnant in Ukraine

    Oct 1, 2017, 00:00

  • Oncologic Pain Attitudes, Intensity And Treatment In Brazil

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Alemtuzumab In Comparison With Natalizumab, Intramuscular Interferon Beta-1a, Subcutaneous Interferon Beta-1b, And Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis In Iran

    Oct 1, 2017, 00:00

  • Applying Nice End Of Life Criteria In The ERA Of Drug Approvals Based On Single-ARM Trial Data

    Oct 1, 2017, 00:00

  • Psychometric Properties Of The EQ-5D-5L In Patients With Major Depression Disorder

    Oct 1, 2017, 00:00

  • Knowledge Of Leptospirosis Among Malaysian Wet Market Sellers

    Oct 1, 2017, 00:00

  • Overview Of Innovative Medicine Sector In Turkey

    Oct 1, 2017, 00:00

  • Cost of Ilness Analysis- A Comparison of The Costs of Drug Therapy for Patients with Prostate Cancer, Breast Cancer, Colon Cancer, Melanoma and Renal Cell Carcinoma in Moscow

    Oct 1, 2017, 00:00

  • Value Frameworks For Cancer Care- Do They Account For Potential Durable Survival With Immunotherapy?

    Oct 1, 2017, 00:00

  • Patient Prefences in Colorectal Adenoma Surveillance

    Oct 1, 2017, 00:00

  • Productivity Costs Related to Bortezomib And Carfilzomib Administration For Multiple Myeloma In Finland

    Oct 1, 2017, 00:00

  • Predictors Of Activity And Participation In People With Motor Neurone Disease, Multiple Sclerosis And Parkinson’s Disease

    Oct 1, 2017, 00:00

  • Pump-Downloaded Insulin Usage For The First 12 Months In A Cohort of Children Newly-Diagnosed With Type 1 Diabetes (T1D)

    Oct 1, 2017, 00:00

  • Mapping The Systematic Review Toolbox

    Oct 1, 2017, 00:00

  • Influenza Vaccination Among Pregnant Women- Exploratory Analysis From The 2012-2015 National Health Interview Survey

    Oct 1, 2017, 00:00

  • A Fresh Look At The Predictors Of The Number Of HIV Cases In Turkey

    Oct 1, 2017, 00:00

  • Budget Impact of IV Iron Therapy with Ferric Carboxymaltose In Patients with Chronic Heart Failure And Iron Deficiency In France

    Oct 1, 2017, 00:00

  • Impact of Isocitrate Dehydrogenase (IDH) Status on the Performance Status and Quality of Life (QOL) of Glioblastoma Multiforme (GBM) Patients

    Oct 1, 2017, 00:00

  • Economic Analysis of The Use of Non-Invasive Prenatal Test (NIPT) For Prenatal Screening of Trisomy 21, 18, 13 In Pregnant Women

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63 (current)
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • »